Skip to content
healthcare.dev

TRANEXAMIC ACID

NDC 43066-008, tranexamic acid, injection, from Baxter Healthcare Corporation.

Product NDC
43066-008
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212360
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43066-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRANEXAMIC ACID100 mg/mL

Pharmacologic classes

Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]

Package NDCNDC-11Package
43066-008-104306600081010 CARTON in 1 BOX (43066-008-10) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (43066-008-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/32750a05-6617-46e8-b9e7-04e613e6bf4b
  • NADAC price for package 43066000810

    GET /v1/drugs/nadac/43066000810

Use it

Look up 43066-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43066-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43066-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.